President Trump Announces Tariffs on Pharmaceuticals, Heavy Trucks, Furniture, and Cabinets for National Security Reasons
President Trump announced a series of import taxes on various goods, set to take effect on October 1st. The new tariffs will impose a 100% tax on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture, and 25% on heavy trucks.
Trump’s persistence with tariffs demonstrates his belief that they will help reduce the federal budget deficit while promoting domestic manufacturing. In a post on his social media platform, Trump justified the new taxes on imported kitchen cabinets and sofas as necessary for “National Security and other reasons.”
The Trade Expansion Act of 1962 provided the legal framework for the administration to launch Section 232 investigations into the impacts of pharmaceutical drug and truck imports on national security. Similarly, a 232 investigation into timber and lumber was initiated in March, though it is unclear whether the furniture tariffs stem from this investigation.
The new tariffs could add uncertainty to an already volatile U.S. economy, with a strong stock market but a faltering job market and elevated inflation. These additional costs on imports may be passed onto consumers in the form of higher prices, potentially dampening hiring and exacerbating the ongoing trends.
Federal Reserve Chair Jerome Powell recently warned that goods price increases have contributed to rising inflation levels this year, accounting for “most” or potentially “all” of the increase. In response to these concerns, Trump has pressured Powell to resign and argued that the Fed should lower interest rates more aggressively. However, economic uncertainty caused by tariffs has led Fed officials to remain cautious on rate cuts.
Trump clarified on his social media platform that the pharmaceutical tariffs would not apply to companies constructing manufacturing plants in the U.S., defined as either breaking ground or being under construction. It is unclear how the tariffs will affect companies with existing factories in the country.
In 2024, America imported nearly $233 billion worth of pharmaceutical and medicinal products, according to Census Bureau data. A potential doubling of prices for some medications could have significant political implications, as health care costs and those associated with Medicare and Medicaid could increase.
Trump’s announcement of pharmaceutical tariffs comes as a surprise, given his previous suggestions that tariffs would be phased in gradually to allow companies time to relocate production. In August, Trump hinted at a “small tariff” on pharmaceuticals, with the rate increasing over a year or more to 150% and even 250%.
Several major pharmaceutical companies have reportedly invested in U.S. production in response to the threat of tariffs earlier this year, including Johnson & Johnson, AstraZeneca, Roche, Bristol Myers Squibb, and Eli Lilly, among others.
Pascal Chan, vice president for strategic policy and supply chains at the Canadian Chamber of Commerce, warned that the new tariffs could negatively impact Americans’ health through immediate price hikes, strained insurance systems, hospital shortages, and the risk of patients rationing or forgoing essential medicines.
The new tariffs on cabinetry could also drive up costs for homebuilders at a time when many potential buyers feel priced out by housing shortages and high mortgage rates. The National Association of Realtors reported signs of price pressures easing in August, with sales listings increasing 11.7% year-over-year, but the median price for an existing home was $422,600.
Trump defended the new taxes on foreign-made heavy trucks and parts as necessary to protect domestic producers from overseas competition. He claimed that manufacturers such as Peterbilt, Kenworth, Freightliner, Mack Trucks, and others would be shielded from external threats.
Trump has long advocated for tariffs as a means of compelling companies to invest more in domestic factories. However, critics argue that importers may pass along much of the cost of these taxes to consumers and businesses in the form of higher prices. Trump’s broader use of country-specific tariffs relies on declaring an economic emergency based on a 1977 law, a move that has faced legal challenges. The Supreme Court is set to hear the case in November.
Despite evidence to the contrary, Trump continues to claim that inflation is no longer a challenge for the U.S. economy. However, the consumer price index has increased by 2.9% over the past year, up from an annual pace of 2.3% in April when Trump initially launched a wide-ranging set of import taxes.
Nor is there evidence that the tariffs are creating factory jobs or more construction of manufacturing facilities. Since April, the Bureau of Labor Statistics has reported that manufacturers have cut 42,000 jobs and builders have downsized by 8,000. Trump acknowledged that his tariffs against China have hurt American farmers but promised to direct revenue from tariffs towards supporting those affected by the conflict, as he did during his first term in 2018 and 2019 when his tariffs led to retaliation against the agricultural sector.